Biotekniikka

Illustration of a cat in a lab with DNA linking to human and dog cancer genes for a news article on feline tumor study.

Study of nearly 500 cat tumors finds cancer-gene overlaps with humans and dogs

24. toukokuuta 2026 Raportoinut AI AI:n luoma kuva Faktatarkistettu

A genetic analysis of 493 tumors from domestic cats collected across five countries found that feline cancers share many of the same cancer-driving genes seen in people and dogs, including frequent FBXW7 mutations in feline mammary tumors that are linked to poorer outcomes in some human breast cancers. The results were published in Science.

Engineered phages redirect vaccine immunity to eradicate tumors in mice

Researchers have used genetically modified phages to harness pre-existing vaccine immunity and destroy cancer cells in mice. The approach eradicated tumors in 44 percent of treated animals with no recurrence after a year.

Managers warn of bioweapon risks from AI and gene tech

24. kesäkuuta 2026 Raportoinut AI

Leading managers from the pharma and tech industries are raising alarms over potential misuse of AI and gene technology for biological weapons.

Eurooppa

HMNC Brain Health raises 50 million dollars

Asia

Oncolys president reflects on journey to world-first cancer treatment

Afrikka

National Biosafety Authority outlines GMO rules in Kenya

Egypt Vaccine City investments to reach EGP 12bn by 2030

Egypt’s Vaccine City and Biotechnology project is expected to attract investments worth EGP 12bn by 2030, according to the Minister of Health and Population.

Longevity startup doses first patient in vision loss trial

09. kesäkuuta 2026 Raportoinut AI

A longevity startup has administered its first dose of a cellular rejuvenation therapy to a patient. The move follows recent FDA approval for human clinical trials of the treatment known as ER-100.

Gene-editing drug slashes bad cholesterol 62 percent in trial

An experimental therapy called VERVE-102 lowered LDL cholesterol by up to 62 percent after a single dose in an early safety study. The results come from a Phase I trial involving 35 patients with high cholesterol or early cardiovascular disease. Data were published this week in the New England Journal of Medicine.

MIT study links dietary cysteine to faster small-intestine repair in mice

21. toukokuuta 2026 Raportoinut AI Faktatarkistettu

MIT researchers report that the amino acid cysteine, found in many protein-rich foods, can enhance the small intestine’s ability to regenerate after injury in mice by triggering an immune-to-stem-cell signaling cascade. The work, published in Nature, raises the possibility—still untested in people—that diet or supplementation could someday help ease some treatment-related intestinal damage during radiation or chemotherapy.

24. kesäkuuta 2026 08.50